CNMD · Conmed Corp
United States · RS rating 66 · As of 2026-10-14
| Price | 44.93 USD |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 66 / 40 / 63 / 51 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 39 / 56 / 45 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +500.0% |
| Sales growth Q/Q | +10.4% |
| Distance from 52-week high | +13.4% |
| Market cap (USD) | $1.2B |